New drugs for reducing cardiovascular risk in women

David G. Vidt, MD
David G. Vidt
MD
Holly L. Thacker, MD
Holly L. Thacker
Associate Director, Menopause Center; Head, Section of Women's Health; Staff, General Internal Medicine and Gynecology and Obstetrics departments, Cleveland Clinic; and Assistant Professor of Internal Medicine, Ohio State University.
MD
and Hussein Saadi, MD
Hussein Saadi
Staff, General Internal Medicine and Endocrinology departments, Cleveland Clinic. Dr. Saadi's major interests are thyroid and lipid disorders and diabetes.
MD

Cleveland Clinic Journal of Medicine
October 1997,
64
(9)
493-502;

ABSTRACT

Atherosclerosis is largely preventable in women. Clinicians need to appreciate the gender-associated risks of cardiovascular disease and emphasize to their women patients that life-style changes can reduce cardiovascular risk. However, newer oral agents for diabetes and the statins for hyperlipidemia are important pharmacological adjuncts.

View Abstract

PDF

Previous Next

In this issue

Print
Download PDF
Article Alerts

Alerts for this Article

User Name *

Password *

Sign In to Email Alerts with your Email Address
Email *
Email Article

Email This Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.
Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following
New drugs for reducing cardiovascular risk in women
Message Subject
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine

Message Body
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Citation Tools
New drugs for reducing cardiovascular risk in women

David G. Vidt

David G. Vidt

Holly L. Thacker

Holly L. Thacker

and Hussein Saadi

Hussein Saadi

Cleveland Clinic Journal of Medicine

October 1997,

64

(9)

493-502;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Share
Share This Article
New drugs for reducing cardiovascular risk in women

David G. Vidt

David G. Vidt

Holly L. Thacker

Holly L. Thacker

and Hussein Saadi

Hussein Saadi

Cleveland Clinic Journal of Medicine

October 1997,

64

(9)

493-502;

Share This Article:
Post